Company signals · MedTech
Boston Scientific Corporation
1 signal in the current window, with MitchelLake's leadership read on each.
Last updated
Market context: The wider read — a Talent Market Index of 122.7 (Hot), up 17.8 month-on-month — shows Americas signal flow rising (+34.4pts).
Boston Scientific Corporation: 1 signal in the last 90 days — in line with the MedTech median of 1 across 18 tracked companies.
Signals at Boston Scientific Corporation
Executive hires, departures and board changes at Boston Scientific Corporation
Every leadership-change and senior-hiring signal observed at Boston Scientific Corporation, newest first, each dated and linked to the source record.
Boston Scientific Corporation signals in the last 90 days
1 public signal observed since 21 July 2026, by type.
More signals across MedTech
Leadership Change · Americas
Owens & Minor →Owens & Minor appointed Carrie Childress as its first Chief Marketing Officer in company history. Childress brings nearly 20 years of healthcare marketing, product management, and brand development experience.
Leadership Change · Americas
McKesson Corporation →Thomas L. Rodgers retired as Executive Vice President and Chief Strategy and Business Development Officer effective August 1, 2026. Ramesh Srinivasan appointed as Executive Vice President and Chief Strategy Officer.
Leadership Change · Americas
Illumina →Illumina appoints Daniel M. Skovronsky, Chief Scientific and Product Officer at Eli Lilly and President of Lilly Research Laboratories, to its Board of Directors, effective June 16, 2026.
Leadership Change · Americas
QuidelOrtho →Appointed Nathaniel Sisitsky as new Chief Legal Officer effective March 23, 2026
Partnership · Americas
CMR Surgical →CMR Surgical and Stryker have formed a strategic alliance granting Stryker an exclusive US commercial agency for the Versius surgical robot portfolio, with CMR retaining commercialisation outside the US.
Product Launch · Americas
Edwards Lifesciences →Edwards Lifesciences received FDA approval for Autus, an expandable pulmonary valve designed for pediatric patients. This is the first FDA-approved heart valve designed to expand post-surgery to accommodate a child's growth.
Where Boston Scientific Corporation's market lands in our work
- Board Search & Advisory →
Incoming executives reshape governance needs within two quarters.
- Executive Search: Americas →
Our Americas practice runs the searches behind signals like this one.
Intelligence powered by Autonodal ↗
- Data period
- 7 Oct 2026 – 7 Oct 2026 · 1 signals for this company
- Methodology
- How this is computed
- Publisher
- MitchelLake
Last updated